Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

Celebrating 30 Years of Innovation Excellence with Advanced OEM Solutions for Healthcare Successful Showcase: ADLINK's latest ...

Learn more about whether Hims & Hers Health, Inc. or Option Care Health, Inc. is a better investment based on AAII's A+ ...

Hims & Hers brought in $1.48 billion in revenue ... perimenopausal and menopausal support." The blood tests also can give the company data on hormone levels, cardiac risk, stress markers ...

lucrative -- clinical categories like low testosterone and menopausal support. Hims & Hers' stock has been on quite a run, up more than 600% in the last year. The company is firing on all ...

Hims & Hers will be able "to support at-home blood draws and more comprehensive whole body testing," HIMS reported. Moreover, the transaction will enable HIMS to offer many more treatments to its ...

Hims & Hers Health reported fourth-quarter revenue of $481.14 million, beating estimates of $470.31 million, according to Benzinga Pro. The company reported fourth-quarter earnings of 11 cents per ...

By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able “to support at-home blood draws and more comprehensive whole body testing,” HIMS reported. Moreover, the transaction ...

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we are going to ...